Improving Follow-up After Treatment for Suspicious Cervical Lesions in Ethiopian Women
Using Nurse Calls, Home Visits, and SMS Reminders
Led by Addis Ababa University · Updated on 2025-06-10
466
Participants Needed
1
Research Sites
5 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effectiveness of three different reminder interventions in improving follow-up adherence among women treated for suspicious cervical lesions in primary healthcare settings in Ethiopia. The study focuses on women who have undergone treatment after positive VIA screening and compares interventions in both HIV-negative and HIV-positive groups. The trial is a pragmatic randomized controlled study led by Addis Ababa University.
The interventions being studied include structured nurse-led telephone call reminders, home visits by health extension workers, and app-based automated SMS text reminders. Each intervention follows a schedule tailored to HIV status for HIV-negative women, reminders start at 4 months post-treatment and continue every 4 months for up to a year for HIV-positive women, reminders begin earlier and are more frequent, occurring every 2 months for 6 months. The control group receives standard care with oral information and a follow-up card.
Participants will be monitored for adherence to follow-up recommendations, specifically re-screening using VIA at about one year after treatment 11-13 months. The study involves scheduled contacts by phone, home visits, or SMS reminders depending on the group assigned. Researchers will measure the proportion of women who adhere to recommended follow-up appointments. The study runs from November 2024 through December 2025 and includes women aged 25 to 49 years, with different age criteria based on HIV status.
CONDITIONS
Brief Title
Key Interventions to Improve the Follow-up Adherence Post Cervical Precancerous Lesion Treatment in Ethiopia
Research Team
M
Mr.Alemnew Destaw Mezgebu, MPH
D
Dr.Muluken Gizaw Turago, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Women treated for suspicious cervical lesions after a positive VIA screening
You will not qualify if you...
History of hysterectomy
Diagnosis of other histological invasive cervical cancer
Suspicious cervical cancer cases
Pregnancy
Prior cervical screening history
Vaginal bleeding
Lack of consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 12 months post-treatment
Participants receive reminders to support adherence to follow-up visits after treatment of suspicious cervical precancerous lesions. Reminders include nurse-led telephone calls, home visits by health extension workers, or automated SMS text messages, depending on the assigned group.
Reminders are given every 2 to 4 months depending on HIV status and intervention group
Follow-up
Duration - At 11 to 13 months post-treatment
Participants attend a follow-up visit for re-screening (VIA) approximately one year after treatment to assess adherence and health status.
1 follow-up visit (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Follow-up rescreening uptake and persistent positive rates among women after positive cervical cancer screening results in Ethiopia: a longitudinal cross-sectional study.
Study protocol for key interventions to improve the follow-up adherence postcervical precancerous lesion treatment in Ethiopia: a pragmatic randomised controlled trial.